AmarHamadMD

Oncology • Oak Lawn, IL

Section Chief of Oncology at Advocate Christ Medical Center serves as Chairman on the Pain & Palliative Care Committee and a member of the Medical Educational Committee Residency Program for Internal Medicine at Advocate Christ Medical Center.

Join to view full profile

Dr. Hamad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hamad's full profile

Already have an account?

Office
4400 W 95th St
Ste 311
Oak Lawn, IL 60453
Phone+1 708-424-9710

Fax+1 708-424-4331

Education & Training

University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 1993 - 1996
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1988 - 1993
Damascus University Faculty of MedicineClass of 1985

Certifications & Licensure

IL State Medical License 1991 - 2026
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy Start of enrollment: 2008 Jun 15
Completed
Phase 3
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
Completed
Phase 2
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2010 Feb 01
Terminated
Phase 3
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Start of enrollment: 2011 Jan 18
Completed
Phase 2
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Start of enrollment: 2010 Sep 15
Terminated
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer Start of enrollment: 2011 Jan 01
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

Paraganglioma of the Neck: A Rare Case With Spinal Metastasis.
Sean McCormack, Eyad Hamad, Amar Hamad
Case Reports in Oncological Medicine. 2024-01-01
Pembrolizumab-Induced Myasthenia Gravis and Peripheral Neuropathy: A Case Series.
Sean M McCormack, Amar Hamad
Cureus. 2023-09-01
1 citations
Solitary Plasmacytoma of the Breast: A Case of an Uncommon Breast Neoplasm.
Sean McCormack, Eyad Hamad, Amar Hamad
Case Reports in Hematology. 2023-01-01

Press Mentions

A Cancer Diagnosis While Pregnant?March 19th, 2018